Glutathione S-transferases as emerging therapeutic targets
- 1 August 2001
- journal article
- Published by Informa Healthcare in Emerging Therapeutic Targets
- Vol. 5 (4) , 477-489
- https://doi.org/10.1517/14728222.5.4.477
Abstract
Glutathione S-transferases (GST) represent a large family of Phase II detoxification enzymes widely expressed in animals and plants. These enzymes catalyse the conjugation of glutathione with some endogenous molecules and a broad range of exogenous substrates including various anticancer drugs. Due to high expression of GSTs in tumours when compared to normal tissues and their high level in plasma from cancer patients, these enzymes are considered to be cancer markers. Their involvement in resistance to anticancer drugs and an inverse correlation between expression and prognosis in many tumours provided a rationale for the design of inhibitors and prodrugs to enhance therapeutic index. The first generation of GST inhibitors included ethacrynic acid and showed promising potentiating activity in vitro but lack of isoenzyme specificity and diuretic side effects restricted clinical use. Novel GST inhibitors include glutathione analogues and demonstrate better specificities with fewer limiting toxicities. One lead compound is a potent inhibitor of the GSTP1-1 isoform in both cell lines and animal models. A GSTP1-1 activated prodrug has also been developed. Testing of the preclinical and clinical efficacy of these agents is presently in progress. Their rational design provides a promising new approach to targeting tumour-specific characteristics in a manner consistent with improving therapeutic index.Keywords
This publication has 40 references indexed in Scilit:
- Identification, Characterization, and Crystal Structure of the Omega Class Glutathione TransferasesJournal of Biological Chemistry, 2000
- Tumor Response to Neoadjuvant Chemotherapy Correlates with the Expression of P-Glycoprotein and PCNA but Not GST-π in the Tumor Cells of Cervical CarcinomaGynecologic Oncology, 1998
- Fibronectin Fragment-Facilitated Retroviral Transfer of the Glutathione-S-Transferase π Gene into CD34+Cells to Protect Them Against Alkylating AgentsHuman Gene Therapy, 1997
- Structure, Catalytic Mechanism, and Evolution of the Glutathione TransferasesChemical Research in Toxicology, 1997
- Markers of Chemoresistance in Ovarian Carcinomas: An Immunohistochemical Study of 86 CasesInternational Journal of Gynecological Pathology, 1996
- Immunohistochemical demonstration of epithelial glutathione S‐transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosaJournal of Oral Pathology & Medicine, 1995
- Isoenzyme-specific glutathione-S-transferase inhibitors: design and synthesisJournal of Medicinal Chemistry, 1994
- Reversing of chlorambucil resistance by ethacrynic acid in a B‐CLL patientBritish Journal of Haematology, 1993
- Immunohistochemical demonstration of glutathione S‐transferases in primary human breast carcinomasThe Journal of Pathology, 1992
- Glutathione S-transferase isoenzymes in human bronchoal veolar lavage: a possible early marker for the detection of lung cancerCarcinogenesis: Integrative Cancer Research, 1990